Table 3. Patients characteristics in the validation cohort.
ControlN=24 | UC patientsN=36 | p-value | |
---|---|---|---|
Age (years) [median (range)] | 70 (34-81) | 70.5 (47-91) | <0.0001 |
Gender n, (%) | |||
Male | 17 (70.8) | 29 (80.6) | 0.386 |
Female | 7 (29.2) | 7 (19.4) | |
Urine cytology n, (%) | |||
Negative | 24 (100) | 20 (55.6) | <0.0001 |
Positive | 0 (0) | 16 (44.4) | |
Creatinine concentration of original urine (mg/dl) [median (range)] | 64.6(10.8-199.1) | 76.6(17.6-261.8) | 0.446 |
UC pathological stage n, (%) | |||
Ta | — | 18 (50.0) | |
T1 | — | 9 (25.0) | |
≧T2 | — | 9 (25.0) | |
UC pathological grade n, (%) | |||
Low grade | — | 9 (25.0) | |
High grade | — | 27 (75.0) | |
UC, urothelial carcinoma. |